CD8 T-cell epitopes vaccine against SARS-CoV-2

Monday, November 2, 2020 4:20 PM to 4:40 PM
World Immunotherapy Congress
Vaccines, neoantigens and oncolytics


  • Selection of T-cell epitopes in stable SARS-CoV-2 genome and high homology with previous CoVs
  • Preclinical vaccination elicits viral-specific Tissue-resident memory T cells
  • Identification of immunodominant CD8 T cell epitopes in convalescent COVID-19 patients

Nicolas Poirier, Chief Scientific Officer, OSE ImmunoTherapeutics